Monopar and NorthStar Announce Filing of Provisional Patent Protecting Development and Use of Radio-Immuno-Therapeutics (RITs) Targeting Severe COVID-19 Through uPAR
Stock Information for Monopar Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.